Strategic Biomarkers for Drug Development in Treating Rare Diseases and Diseases in Neonates and Infants
Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 2
Abstract
There are similar challenges in developing a product designed to treat patients with a rare disease and drugs to treat critically ill neonates and infants. Part of the challenge in developing such products as well as identifying the optimal dosing regimen for the treatment of young children arises from the complex interrelationship between developmental changes and changes in biomarkers responsive to drug therapy. These difficulties are further compounded by our lack of understanding of the key physiological factors that cause the differences in clinical responses between adults and neonates and infants. Regulatory efforts have succeeded in overcoming these challenges in many areas of pediatric and orphan drug development. Strategic applications of biomarkers and surrogate endpoints for the development and approval of a product used to treat an orphan disease will be highlighted with examples of approved products. Continued efforts are still needed to fill in our knowledge gap and to strategically link biomarkers and surrogate endpoints to clinical responses for rare diseases and diseases affecting neonates and infants.
Authors and Affiliations
Jane P. F. Bai, Jeffrey S. Barrett, Gibert J. Burckart, Bernd Meibohm, Hari Cheryl Sachs, Lynne Yao
Keywords
Related Articles
- EP ID EP681114
- DOI 10.1208/s12248-013-9452-z
- Views 78
- Downloads 0
The Population Pharmacokinetics of d -β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
The online version of this article (doi:10.1208/s12248-016-9879-0) contains supplementary material, which is available to authorized users.
Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model
This study was undertaken to determine whether the gravimetric method provided an accurate measure of water flux correction and to compare the gravimetric method with methods that employ nonabsorbed markers (eg, phenol r...
Symbiotic relationship of pharmacogenetics and drugs of abuse
Pharmacogenetics/pharmacogenomics is the study of how genetic variation affects pharmacology, the use of drugs to treat disease. When drug responses are predicted in advance, it is easier to tailor medications to differe...
A semiautomated approach to gene discovery through expressed sequence tag data mining: Discovery of new human transporter genes
Identification and functional characterization of the genes in the human genome remain a major challenge. A principal source of publicly available information used for this purpose is the National Center for Biotechnolog...
Unbiased membrane permeability parameters for gabapentin using boundary layer approach
The present study was performed to determine the relative contribution of both passive and nonpassive transport processes in jejunal absorption of gabapentin. The oral absorption of gabapentin was studied using in situ s...